BALTIMORE, MD, September 9, 2025 \u2014 Sapio Sciences<\/a>, the AI lab informatics company<\/a>, today announced a strategic partnership with Ultima Genomics<\/a>. The collaboration will make multi-omics workflows more accessible and streamlined for researchers by integrating Sapio\u2019s AI-powered lab informatics solutions with Ultima\u2019s high-throughput, low-cost sequencing platform. Together, the companies will deliver efficient, traceable, and unified workflows for multi-omics research and clinical genomics.<\/p>\n\n\n\n Ultima Genomics is known for its innovative ultra-high throughput sequencing architecture, designed to drive down sequencing costs and scale beyond conventional technologies. Its multiomics sequencing capabilities allow researchers to study layers of biology beyond DNA sequences alone. Many changes linked to disease occur first in other omic layers, such as in the epigenome with cancer.<\/p>\n\n\n\n Deeper levels of analysis are increasingly important for understanding complex biology, but until now have often required multiple costly assays and fragmented workflows. This integration allows researchers and clinicians to combine Ultima\u2019s data generation capabilities with Sapio\u2019s analytics, automation, and data management tools for a seamless, end-to-end solution.<\/p>\n\n\n\n Gilad Almogy, CEO and founder of Ultima Genomics, commented, \u201cPartnering with Sapio Sciences aligns with our goals to enable leading sequencing labs and make genomic information more scalable. By integrating our high-throughput, low-cost sequencing platform with Sapio\u2019s AI-powered lab informatics platform, we\u2019re enabling a seamless, scalable solution for multi-omics research and clinical genomics. <\/p>\n\n\n\n Almogy continued, \u201cWe\u2019re excited to empower organizations to accelerate discovery, drive AI-powered insights, and bring high-quality genomics into everyday workflows with unmatched efficiency and traceability.\u201d<\/p>\n<\/blockquote>\n\n\n\n \u201cThis partnership gives Ultima\u2019s customers a direct path to combining world-class sequencing with equally powerful informatics,\u201d said Andrew Wyatt, chief growth officer at Sapio Sciences. \u201cBy removing workflow complexity, we\u2019re making it easier for labs to manage multi-omics data, gain insights faster, and scale without compromising quality or compliance.\u201d<\/p>\n<\/blockquote>\n\n\n\n The Sapio Sciences Partner Program<\/a> connects innovators with Sapio\u2019s industry-leading lab informatics platform, fostering integrations that deliver measurable benefits to customers. It includes three partner ecosystems:<\/p>\n\n\n\n Sapio Sciences delivers the Sapio Platform<\/a>, an agentic AI lab informatics platform for biopharma R&D, clinical diagnostics and manufacturing. Built on a shared foundation, the Sapio Platform unifies Sapio LIMS<\/a> and Sapio ELN<\/a> in one configurable environment, with Sapio Elain<\/a>, the AI co-scientist, orchestrating intelligence across every workflow. Learn more at www.sapiosciences.com<\/a> and follow Sapio Sciences on LinkedIn<\/a>.<\/p>\n\n\n\n Ultima Genomics is unleashing the power of genomics at scale. The Company’s mission is to continuously drive the scale of genomic information to enable unprecedented advances in biology and improvements in human health. With humanity on the cusp of a biological revolution, there is a virtually endless need for more genomic information to address biology’s complexity and dynamic change\u2014and a further need to challenge conventional next-generation sequencing technologies. <\/p>\n\n\n\n Ultima’s revolutionary new sequencing architecture drives down the costs of sequencing to help overcome the tradeoffs that scientists and clinicians are forced to make between the breadth, depth and frequency with which they use genomic information. The new sequencing architecture was designed to scale far beyond conventional sequencing technologies, lower the cost of genomic information and catalyze the next phase of genomics in the 21st century. <\/p>\n\n\n\n To learn more, visit www.ultimagenomics.com<\/a><\/p>\n\n\n\n Tim Brook, Sapio Sciences<\/p>\n\n\n\n press@sapiosciences.com<\/a><\/p>\n\n\n\n Vikki Herrera, Ultima Media Contact<\/p>\n\n\n\n vikki@oakstreetcommunications.com<\/p>\n\n\n\n 1. What is the Sapio Sciences and Ultima Genomics partnership?<\/strong> 2. Who is this partnership designed to support?<\/strong> 3. What are the benefits of using Sapio and Ultima together?<\/strong> 4. How does this integration support multi-omics research?<\/strong> 5. Where can I learn more about the integrated solution?<\/strong>\n
Key Benefits for Customers<\/h3>\n\n\n\n
\n
\n
Sapio Sciences Partner Program<\/h3>\n\n\n\n
\n
About Sapio Sciences<\/h3>\n\n\n\n
About Ultima Genomics<\/h3>\n\n\n\n
Media Inquiries<\/h3>\n\n\n\n
FAQ<\/h3>\n\n\n\n
Sapio Sciences and Ultima Genomics have entered a technology partnership to integrate their platforms. The collaboration combines Sapio\u2019s AI-powered lab informatics with Ultima\u2019s high-throughput, low-cost sequencing, supporting more efficient and traceable multi-omics workflows.<\/p>\n\n\n\n
This solution is intended for researchers and clinical teams working in multi-omics, including genomics, transcriptomics, proteomics, and other data-intensive life science fields. It helps streamline workflows and improve data integration and analysis.<\/p>\n\n\n\n
Customers can benefit from unified workflows, reduced per-sample sequencing costs, faster discovery cycles through automation and analytics, and improved traceability for compliance and audit purposes.<\/p>\n\n\n\n
By connecting sequencing output with lab data management and analytics, the partnership simplifies how researchers handle large and complex datasets. It reduces the need for multiple tools and manual processes in multi-omics studies.<\/p>\n\n\n\n
For more details on how the platforms work together or to explore partnership opportunities, visit www.sapiosciences.com<\/a> and www.ultimagenomics.com<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"Partnership delivers global, end-to-end solutions to accelerate genomics research BALTIMORE, MD, September 9, 2025 \u2014 Sapio Sciences, the AI lab informatics company, today announced a strategic partnership with Ultima Genomics. The collaboration will make multi-omics workflows more accessible and streamlined for researchers by integrating Sapio\u2019s AI-powered lab informatics solutions with Ultima\u2019s high-throughput, low-cost sequencing platform. […]","protected":false},"featured_media":0,"parent":0,"template":"","class_list":["post-20110","news","type-news","status-publish","hentry"],"acf":[],"yoast_head":"\n